Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Learn why financial planning is crucial for achieving long-term financial stability. Don't leave your future to chance—plan wisely.
24,037 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
A ChatGPT-powered forecast associated with Sam Altman lays out a bullish Bitcoin scenario for late 2026, highlighting...
As Apple eyes a leadership transition, analysts debate whether Apple stock will outpace the S&P 500 in the new CEO’s ...
XRP faces a pivotal test as a new AI-driven forecast hints at a multi-dollar rally by the end of 2026, even as the to...
The United States is imposing 25% tariffs on imports from Brazil, with exemptions for key items like coffee and beef....
Trump Media plans a rapid data feed of Truth Social posts for market participants, a move that could reshape timing i...
Meta Platforms is delivering stronger fundamentals even as the stock trades at a cautious multiple. This article argu...
Bitcoin's Divergence From Nasdaq raises questions about dollar liquidity and credit conditions. This article breaks d...
A major fund trimmed its AvePoint stake, triggering a sharp move in AVPT. This piece breaks down what happened, why i...
Tesla stock has dipped below $400 again, prompting questions about a potential buy. This guide weighs growth drivers ...
Marc Zeller’s audit of Aave Labs has sparked new tensions in the AaveDAO as supporters and critics spar over a $51 mi...
Salesforce just delivered a solid quarter with revenue and adjusted earnings topping expectations and a $50 billion b...